The stock of Lifeward Ltd (LFWD) has seen a 19.17% increase in the past week, with a -35.43% drop in the past month, and a -47.73% decrease in the past quarter. The volatility ratio for the week is 11.00%, and the volatility levels for the past 30 days are at 11.25% for LFWD. The simple moving average for the past 20 days is -14.55% for LFWD’s stock, with a -56.70% simple moving average for the past 200 days.
Is It Worth Investing in Lifeward Ltd (NASDAQ: LFWD) Right Now?
LFWD has 36-month beta value of 0.08. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for LFWD is 14.97M, and currently, short sellers hold a 2.90% ratio of that float. The average trading volume of LFWD on July 09, 2025 was 569.37K shares.
LFWD) stock’s latest price update
Lifeward Ltd (NASDAQ: LFWD) has seen a rise in its stock price by 15.95% in relation to its previous close of $0.66. However, the company has experienced a 19.17% gain in its stock price over the last five trading sessions. prnewswire.com reported 2025-07-07 that Industry veteran with proven track record in neurorehabilitation and fundraising to lead next phase of growth; Co-founder Brian Harris transitions to Chief Scientific Officer PORTLAND, Maine, July 7, 2025 /PRNewswire/ — MedRhythms, Inc., a company pioneering the development of next-generation neurotherapeutics to improve walking, mobility and related functional outcomes, and creator of the world’s first prescription music platform, announced the appointment of Larry Jasinski as Chief Executive Officer, effective immediately. Co-founder of MedRhythms, Brian Harris, who led the company through product development, successful clinical trials, listing product with the Food and Drug Administration (FDA), and assignment by the Centers for Medicare and Medicaid Services (CMS) of a benefit category and unique Health Care Common Procedure Coding System (HCPCPS) code, will transition to the role of Chief Scientific Officer (CSO) and work with Larry to build the market and grow the company in its next phase.
Analysts’ Opinion of LFWD
Many brokerage firms have already submitted their reports for LFWD stocks, with Laidlaw repeating the rating for LFWD by listing it as a “Buy.” The predicted price for LFWD in the upcoming period, according to Laidlaw is $10 based on the research report published on February 10, 2025 of the current year 2025.
Barclays, on the other hand, stated in their research note that they expect to see LFWD reach a price target of $1.50, previously predicting the price at $2.50. The rating they have provided for LFWD stocks is “Underweight” according to the report published on April 03rd, 2017.
LFWD Trading at -33.32% from the 50-Day Moving Average
After a stumble in the market that brought LFWD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.89% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFWD starting from Jasinski Lawrence J, who sale 1,909 shares at the price of $1.26 back on May 21 ’25. After this action, Jasinski Lawrence J now owns 98,728 shares of Lifeward Ltd, valued at $2,405 using the latest closing price.
Lind Global Fund II LP, the 10% Owner of Lifeward Ltd, sale 381,676 shares at $3.36 during a trade that took place back on Jan 06 ’25, which means that Lind Global Fund II LP is holding 1,049,430 shares at $1,283,102 based on the most recent closing price.
Stock Fundamentals for LFWD
Current profitability levels for the company are sitting at:
- -0.87 for the present operating margin
- 0.33 for the gross margin
The net margin for Lifeward Ltd stands at -0.89. The total capital return value is set at 2.42. Equity return is now at value -93.11, with -65.46 for asset returns.
Based on Lifeward Ltd (LFWD), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -31.56. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -343.7.
Currently, EBITDA for the company is -19.55 million with net debt to EBITDA at -0.04. When we switch over and look at the enterprise to sales, we see a ratio of 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.18.
Conclusion
To put it simply, Lifeward Ltd (LFWD) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
